The purpose of this study is to investigate the efficacy and safety of NT 201 injections in the treatment of enlarged pores and excessive sebum production in the face.
Eligible subjects will be randomized to one of the two treatment groups: NT 201 group and placebo in order to receive one session of injections with either NT 201 or placebo in the upper face (forehead and cheek area) on Day 1 and followed for about 90 days after treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
31
Merz Investigation Site #0010473
Los Angeles, California, United States
Merz Investigation Site #0010101
Coral Gables, Florida, United States
Merz Investigation Site #001097
Nashville, Tennessee, United States
Change from Baseline to Week 4 in Pore Volume in the Cheek Area
Antera 3D will be used as an assessment tool.
Time frame: Baseline (Day 1), Week 4
Change from Baseline to Week 4 in Sebum Level in the Forehead Area
Sebumeter will be used as an assessment tool.
Time frame: Baseline (Day 1), Week 4
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.